TrialFrontiers in immunology2021

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis.

Liam J O'Neil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.